An exploratory analysis of wineries websites functionality: the case of the DOQ Priorat Route Wineries

Texto resumen

Análisis exploratorio de la funcionalidad de las páginas web de los viñedos del Priorat: el caso de las bodegas de la ruta del vino de la Denominación de Origen de Calidad Priorat

Texto resumen

El colesterol sigue alto. ¿Y ahora qué hacemos? Tratamiento de la hipercolesteremia no controlada a lo largo de un año

ObjetivoConocer la efectividad sobre el control lipídico del tratamiento hipolipemiante, basado en la práctica clínica habitual en atención primaria, en pacientes con hipercolesteremia manifiesta.DiseñoIntervención semiexperimental, antes-después.EmplazamientoCentro de salud urbano. Participantes: 187 pacientes dislipémicos conocidos, con colesterol total o colesterol LDL (cLDL) > 270 o 190 mg/dl, respectivamente.IntervenciónPráctica clínica habitual durante 12 meses en 9 consultas de atención primaria.Mediciones principalesSe registró el perfil lipídico y el tratamiento hipolipemiante al inicio del estudio y al cabo de 12 meses. El control lipídico (en función del cLDL) se evaluó como óptimo, aceptable y deficiente en función del riesgo cardiovascular según los criterios de la Sociedad Española de Arteriosclerosis (1994).ResultadosEn un 27% de casos no se registró ninguna visita relacionada con la hipercolesteremia por su médico. El número de pacientes tratados con hipolipemiantes creció de 50 a 98 (27 frente a 52%; p < 0,005), fundamentalmente a expensas del uso de estatinas. Tras 12 meses, se observaron descensos significativos en la concentración plasmática del cLDL (12%; IC del 95%, 9–15%) y del porcentaje de pacientes con control deficiente, que descendió del 91% inicial al 61% (p < 0,005), aunque sólo un 16% alcanzó un control óptimo.ConclusionesTras un año, con las condiciones de práctica clínica habitual, se observó un incremento en el uso de hipolipemiantes y una mejoría en el control lipídico, aunque algo más de la mitad de los pacientes (61%) con hipercolesteremia manifiesta permanecen con concentraciones tributarias de tratamiento.ObjectiveTo find the effectiveness of lipid-lowering treatment, based on normal clinical practice in primary care, on lipid control of patients with clear hypercholesterolaemia (HC).DesignSemi-experimental before-and-after intervention study.SettingUrban health centre. Participants: 187 patients known to have lipaemia, with total or LDL cCholesterol (cLDL) above 270 and 190 mg/dl, respectivelyInterventionNormal clinical practice for twelve months in nine primary care clinicsMain measurementsThe lipid profile and lipid-lowering treatment were recorded at the start of the study and after twelve months. Lipid control (as a function of cLDL) was evaluated as optimal, acceptable or deficient, as a function of the cardiovascular risk, following the criteria of the Spanish Arteriosclerosis Society (1994)ResultsIn 27% of cases, no visit relating to HC was recorded by the patient´s doctor. The number of patients treated with lipid-lowering drugs grew from 50 to 98 (27 vs 52%, p < 0,005), fundamentally at the expense of statin treatment. After twelve months, there were significant drops in the plasma concentration of cLDL (12%, 95%CI, 9 to 15%) and in the percentage of patients with deficient control, which fell from the initial 91% to 61% (p < 0.005), although only 16% reached optimal control.ConclusionsAfter a year, under conditions of normal clinical practice, there was an increase in the use of lipid-lowering drugs and improvement in lipid control, though a bit over half the patients (61%) with clear hypercholesterolaemia maintained concentrations requiring treatment

Galectin-3 shapes toxic alpha-synuclein strains in Parkinson's disease.

Parkinson's Disease (PD) is a neurodegenerative and progressive disorder characterised by intracytoplasmic inclusions called Lewy bodies (LB) and degeneration of dopaminergic neurons in the substantia nigra (SN). Aggregated α-synuclein (αSYN) is known to be the main component of the LB. It has also been reported to interact with several proteins and organelles. Galectin-3 (GAL3) is known to have a detrimental function in neurodegenerative diseases. It is a galactose-binding protein without known catalytic activity and is expressed mainly by activated microglial cells in the central nervous system (CNS). GAL3 has been previously found in the outer layer of the LB in post-mortem brains. However, the role of GAL3 in PD is yet to be elucidated. In post-mortem samples, we identified an association between GAL3 and LB in all the PD subjects studied. GAL3 was linked to less αSYN in the LB outer layer and other αSYN deposits, including pale bodies. GAL3 was also associated with disrupted lysosomes. In vitro studies demonstrate that exogenous recombinant Gal3 is internalised by neuronal cell lines and primary neurons where it interacts with endogenous αSyn fibrils. In addition, aggregation experiments show that Gal3 affects spatial propagation and the stability of pre-formed αSyn fibrils resulting in short, amorphous toxic strains. To further investigate these observations in vivo, we take advantage of WT and Gal3KO mice subjected to intranigral injection of adenovirus overexpressing human αSyn as a PD model. In line with our in vitro studies, under these conditions, genetic deletion of GAL3 leads to increased intracellular αSyn accumulation within dopaminergic neurons and remarkably preserved dopaminergic integrity and motor function. Overall, our data suggest a prominent role for GAL3 in the aggregation process of αSYN and LB formation, leading to the production of short species to the detriment of larger strains which triggers neuronal degeneration in a mouse model of PD

An alternative approach to implement a recursive interpolation

Peer ReviewedPostprint (published version

A socio-ecological approach to reduce the physical activity drop-out ratio in primary care-based patients with type 2 diabetes: the SENWI study protocol for a randomized control trial

BACKGROUND: Physical activity (PA) is a key behaviour for patients with type 2 diabetes (T2DM). However, healthcare professionals' (HCP) recommendations (walking advice), which are short-term and individually focused, did not reduce the PA drop-out ratio in the long run. Using a socio-ecological model approach may contribute to reducing patient dropout and improving adherence to PA. The aim of this study is threefold: first, to evaluate the effectiveness of a theory-driven Nordic walking intervention using a socio-ecological approach with T2DM patients in Spain; second, to explore the feasibility on the PA adherence process in T2DM patients while participating in the SENWI programme; and third, to understand the HCPs' opinion regarding its applicability within the Spanish healthcare system. METHODS: A three-arm randomized control trial (n = 48 each group) will assess the efficacy of two primary care-based PA interventions (Nordic walking vs. Nordic walking plus socio-ecological approach; two sessions per week for twelve weeks) compared to a control group (usual HCPs' walking advice on PA). Inclusion criteria will include physically inactive patients with T2DM, older than 40 years and without health contraindications to do PA. PA levels and drop-out ratio, quality of life and metabolic and health outcomes will be assessed at baseline, post-intervention and at 9- and 21-month follow-ups. The effect of the different interventions will be assessed by a two-factor analysis of variance: treatment group vs time. Also, a two-factor ANOVA test will be performed with linear mixed models for repeated measures. A qualitative analysis using focus groups will explore the reasons for the (in)effectiveness of the new PA interventions. Qualitative outcomes will be assessed at post-intervention using thematic analysis. DISCUSSION: Compared with the general PA walking advice and Nordic walking prescriptions, integrating a socio-ecological approach into Spanish primary care visits could be an effective way to reduce the PA drop-out ratio and increase PA levels in patients with T2DM. Such interventions are necessary to understand the role that multiple socio-complex process in day-to-day PA behaviour has in patients with T2DM in the Spanish context. TRIAL REGISTRATION: ClinicalTrials.gov NCT05159089. Physical Activity Drop-out Ratio in Patients' Living with Type 2 Diabetes. Prospectively registered on 15 December 2021

The Poopó polymetallic epithermal deposit, Bolivia: mineralogy, genetic constraints, and distribution of critical elements

The tin-rich polymetallic epithermal deposit of Poopó, of plausible Late Miocene age, is part of the Bolivian Tin Belt. As an epithermal low sulfidation mineralisation, it represents a typological end-member within the “family” of Bolivian tin deposits. The emplacement of the mineralisation was controlled by the regional fault zone that constitutes the geological border between the Bolivian Altiplano and the Eastern Andes Cordillera. In addition to Sn and Ag, its economic interest resides in its potential in critical elements as In, Ga and Ge. This paper provides the first systematic characterisation of the complex mineralogy and mineral chemistry of the Poopó deposit with the twofold aim of identifying the mineral carriers of critical elements and endeavouring to ascertain plausible metallogenic processes for the formation of this deposit, by means of a multi-methodological approach. The poor development of hydrothermal alteration assemblage, the abundance of sulphosalts and the replacement of löllingite and pyrrhotite by arsenopyrite and pyrite, respectively, indicate that this deposit is ascribed to the low-sulphidation subtype of epithermal deposits, with excursions into higher states of sulphidation. Additionally, the occurrence of pyrophyllite and topaz has been interpreted as the result of discrete pulses of high-sulphidation magmatic fluids. The d34SVCDT range in sulphides (-5.9 to -2.8‰) is compatible either with: (i) hybrid sulphur sources (i.e., magmatic and sedimentary or metasedimentary); or (ii) a sole magmatic source involving magmas that derived from partial melting of sedimentary rocks or underwent crustal assimilation. In their overall contents in critical elements (In, Ga and Ge), the key minerals in the Poopó deposit, based on their abundance in the deposit and compositions, are rhodostannite, franckeite, cassiterite, stannite and, less importantly, teallite, sphalerite and jamesonite.Peer ReviewedPostprint (published version

Indium mineralization in the volcanic dome-hosted Ánimas–Chocaya–Siete Suyos polymetallic deposit, Potosí, Bolivia

A volcanic dome complex of Miocene age hosts the In-bearing Ánimas–Chocaya–Siete Suyos district in SW Bolivia. Ore mineralization occurs as banded and massive infillings in subvertical, NE-SW striking veins. In this article, a detailed petrographic study is combined with in situ mineral geochemistry determinations in ore from the Arturo, Chorro and Diez veins in the Siete Suyos mine, the Ánimas, Burton, Colorada, and Rosario veins in the Ánimas mine and the Nueva vein in the Chocaya mine. A three-stage paragenetic sequence is roughly determined for all of them, and includes (1) an early low-sulfidation stage that is dominated by cassiterite, pyrrhotite, arsenopyrite, and high-Fe sphalerite (FeS > 21 mol. %); (2) a second intermediate-sulfidation stage dominated by pyrite + marcasite ± intermediate product, sphalerite (FeS < 21 mol. %), stannite, and local famatinite; and, (3) a late intermediate-sulfidation stage dominated by galena and Ag-Pb-Sn sulfosalts. Electron-probe microanalyses reveal high indium enrichment in stage-2 sphalerite (up to 9.66 wt.% In) and stannite (up to 4.11 wt.% In), and a moderate enrichment in rare wurtzite (up to 1.61 wt.% In), stage-1 sphalerite (0.35 wt.% In), cassiterite (up to 0.25 wt.% In2O3), and ramdohrite (up to 0.24 wt.% In). Therefore, the main indium mineralization in the district can be associated to the second, intermediate-sulfidation stage, chiefly in those veins in which sphalerite and stannite are more abundant. Atomic concentrations of In and Cu in sphalerite yield a positive correlation at Cu/In = 1 that agrees with a (Cu+ + In3+) ¿ 2Zn2+ coupled substitution. The availability of Cu in the mineralizing fluids during the crystallization of sphalerite is, in consequence, essential for the incorporation of indium in its crystal lattice and would control the distribution of indium enrichment at different scales. The highest concentrations of indium in sphalerite, which is found in the Diez vein in the Siete Suyos mine, occur in crustiform bands of sphalerite with local “chalcopyrite disease” texture, which has not been observed in the other studied veins. In stannite, the atomic concentrations of In are negatively correlated with those of Cu and Sn at Cu + In = 2 and Sn + In = 1. Thus, atomic proportions and correlations suggest the contextualization of the main indium mineralization in the sphalerite–stannite–roquesite pseudoternary system.Peer ReviewedPostprint (published version

The Poopó Polymetallic Epithermal Deposit, Bolivia: Mineralogy, Genetic Constraints, and Distribution of Critical Elements

The tin-rich polymetallic epithermal deposit of Poopó, of plausible Late Miocene age, is part of the Bolivian Tin Belt. As an epithermal low sulfidation mineralisation, it represents a typological end-member within the "family" of Bolivian tin deposits. The emplacement of the mineralisation was controlled by the regional fault zone that constitutes the geological border between the Bolivian Altiplano and the Eastern Andes Cordillera. In addition to Sn and Ag, its economic interest resides in its potential in critical elements as In, Ga and Ge. This paper provides the first systematic characterisation of the complex mineralogy and mineral chemistry of the Poopó deposit with the twofold aim of identifying the mineral carriers of critical elements and endeavouring to ascertain plausible metallogenic processes for the formation of this deposit, by means of a multi-methodological approach. The poor development of hydrothermal alteration assemblage, the abundance of sulphosalts and the replacement of löllingite and pyrrhotite by arsenopyrite and pyrite, respectively, indicate that this deposit is ascribed to the low-sulphidation subtype of epithermal deposits, with excursions into higher states of sulphidation. Additionally, the occurrence of pyrophyllite and topaz has been interpreted as the result of discrete pulses of high-sulphidation magmatic fluids. The δ34SVCDT range in sulphides (−5.9 to −2.8 ) is compatible either with: (i) hybrid sulphur sources (i.e., magmatic and sedimentary or metasedimentary); or (ii) a sole magmatic source involving magmas that derived from partial melting of sedimentary rocks or underwent crustal assimilation. In their overall contents in critical elements (In, Ga and Ge), the key minerals in the Poopó deposit, based on their abundance in the deposit and compositions, are rhodostannite, franckeite, cassiterite, stannite and, less importantly, teallite, sphalerite and jamesonite

Preoperative oral antibiotic prophylaxis reduces Pseudomonas aeruginosa surgical site infections after elective colorectal surgery: a multicenter prospective cohort study

BACKGROUND: Healthcare-associated infections caused by Pseudomonas aeruginosa are associated with poor outcomes. However, the role of P. aeruginosa in surgical site infections after colorectal surgery has not been evaluated. The aim of this study was to determine the predictive factors and outcomes of surgical site infections caused by P. aeruginosa after colorectal surgery, with special emphasis on the role of preoperative oral antibiotic prophylaxis. METHODS: We conducted an observational, multicenter, prospective cohort study of all patients undergoing elective colorectal surgery at 10 Spanish hospitals (2011-2014). A logistic regression model was used to identify predictive factors for P. aeruginosa surgical site infections. RESULTS: Out of 3701 patients, 669 (18.1%) developed surgical site infections, and 62 (9.3%) of these were due to P. aeruginosa. The following factors were found to differentiate between P. aeruginosa surgical site infections and those caused by other microorganisms: American Society of Anesthesiologists' score III-IV (67.7% vs 45.5%, p = 0.001, odds ratio (OR) 2.5, 95% confidence interval (95% CI) 1.44-4.39), National Nosocomial Infections Surveillance risk index 1-2 (74.2% vs 44.2%, p < 0.001, OR 3.6, 95% CI 2.01-6.56), duration of surgery ≥75thpercentile (61.3% vs 41.4%, p = 0.003, OR 2.2, 95% CI 1.31-3.83) and oral antibiotic prophylaxis (17.7% vs 33.6%, p = 0.01, OR 0.4, 95% CI 0.21-0.83). Patients with P. aeruginosa surgical site infections were administered antibiotic treatment for a longer duration (median 17 days [interquartile range (IQR) 10-24] vs 13d [IQR 8-20], p = 0.015, OR 1.1, 95% CI 1.00-1.12), had a higher treatment failure rate (30.6% vs 20.8%, p = 0.07, OR 1.7, 95% CI 0.96-2.99), and longer hospitalization (median 22 days [IQR 15-42] vs 19d [IQR 12-28], p = 0.02, OR 1.1, 95% CI 1.00-1.17) than those with surgical site infections due to other microorganisms. Independent predictive factors associated with P. aeruginosa surgical site infections were the National Nosocomial Infections Surveillance risk index 1-2 (OR 2.3, 95% CI 1.03-5.40) and the use of oral antibiotic prophylaxis (OR 0.4, 95% CI 0.23-0.90). CONCLUSIONS: We observed that surgical site infections due to P. aeruginosa are associated with a higher National Nosocomial Infections Surveillance risk index, poor outcomes, and lack of preoperative oral antibiotic prophylaxis. These findings can aid in establishing specific preventive measures and appropriate empirical antibiotic treatment